Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
9.28
-0.27 (-2.83%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $121.14 million as of October 31, 2024. Its market cap has increased by 61.09% in one year.
Market Cap
121.14M
Enterprise Value
120.67M
1-Year Change
61.09%
Ranking
Category
Stock Price
$9.28
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $56.80M to $121.14M, an increase of 113.28%. That is a compound annual growth rate of 17.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 124.70M | -35.02% |
Dec 29, 2023 | 191.90M | 75.09% |
Dec 30, 2022 | 109.60M | -23.03% |
Dec 31, 2021 | 142.40M | 173.85% |
Dec 31, 2020 | 52.00M | -8.45% |
Jan 29, 2020 | 56.80M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fractyl Health | 132.28M |
Fennec Pharmaceuticals | 129.70M |
Scilex Holding Company | 129.40M |
Werewolf Therapeutics | 129.36M |
Anixa Biosciences | 127.75M |
23andMe Holding Co. | 125.31M |
Journey Medical | 124.36M |
Invivyd | 124.22M |